Seeing Is Believing
Currently out of the existing stock ratings of Joseph Pantginis, 668 are a BUY (96.53%), 23 are a HOLD (3.32%), 1 are a SELL (0.14%).
Analyst Joseph Pantginis, currently employed carries an average stock price target met ratio of 31.41% that have a potential upside of 42.14% achieved within 243 days. Previously, Joseph Pantginis worked at HC WAINWRIGHT.
Joseph Pantginis’s has documented 1,261 price targets and ratings displayed on 68 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ESPR, Esperion Therapeutics at 02-Oct-2024.
Analyst best performing recommendations are on PROG (PROGENITY).
The best stock recommendation documented was for VKTX (VIKING THERAPEUTICS) at 2/27/2024. The price target of $90 was fulfilled within 1 day with a profit of $4.95 (5.82%) receiving and performance score of 58.2.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$18.75
$4.15 (28.42%)
4 years 4 months 9 days ago
0/8 (0%)
$5.9 (45.91%)
Which stock is Joseph Pantginis is most bullish on?
Which stock is Joseph Pantginis is most reserved on?
What Year was the first public recommendation made by Joseph Pantginis?